NCT03705481View on ClinicalTrials.gov

GRX With ReMOTE: First in Human in India

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

December 6, 2018

Study Completion Date

December 7, 2018

Conditions
Percutaneous Coronary Intervention
Interventions
DEVICE

Remote treatment of PCI.

To evaluate the safety and performance of CorPath GRX POP System, in the ReMOTE (location outside hospital) delivery and manipulation of coronary guidewires and stent/balloon catheters, and manipulation of guide catheters during PCI procedures.

Trial Locations (1)

380054

Apex Heart Institute, Ahmedabad

All Listed Sponsors
lead

Corindus Inc.

INDUSTRY

NCT03705481 - GRX With ReMOTE: First in Human in India | Biotech Hunter | Biotech Hunter